We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Heart Disease Marker in PCOS Women

By HospiMedica staff writers
Posted on 20 Sep 2005
Women with polycystic ovary syndrome (PCOS) may also be at increased risk for cardiovascular disease, as evidenced by endothelial dysfunction, an early marker for atherosclerosis.

Researchers at University Hospital in Ioannina (Greece) studied endothelial function in women with PCOS compared to normal women and also investigated the determinants of endothelial dysfunction in women with PCOS and its relationship with body mass index (BMI). More...
Their study involved 62 young women with PCOS whose average age was 22.7 years, with 17 controls matched for age and BMI. Twenty-three of the women with PCOS were lean, 21 were overweight, and 18 were obese. The researchers assessed endothelium-dependent and independent vascular function noninvasively by measuring flow-mediated and nitrate-mediated dilation in the brachial artery of the arm.

Those women with PCOS showed significant endothelial dysfunction as soon as their early twenties. This marker is evident in women with PCOS regardless of their weight and, although it appears to deteriorate with increasing BMI, this was not found statistically significant. The findings, reported in the September 20005 issue of the Journal of Endocrinology and Metabolism, suggest that women with PCOS are at risk for early-onset cardiovascular problems and will benefit from a treatment program that incorporates healthful lifestyle and cardio-protective measures in addition to treatment for PCOS.






Related Links:
University Hospital

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.